18 February 2021 in Cardiovascular Therapy and Prevention
Синдром Хейда, как редкая причина желудочно-кишечных кровотечений у больных с аортальным стенозом
28 December 2021 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Aorto-digestive fistulas are a rare but extremely dangerous cause of massive gastrointestinal bleeding with a high risk of death. The aim of the review was to examine the modern principles of aorto-digestive fistula diagnosis and optimal treatment modalities.Scientific publications and their reference lists were searched on PubMed database, Google Scholar and Russian Science Citation Index. Articles relevant to the topic, published over the past 25 years (1996-2021), were included and they were searched and categorised using the following key words: ‘gastrointestinal bleeding’, ‘aorto-digestive fistulas’, ‘diagnosis’ and ‘treatment’. Inclusion criteria were limited to gastrointestinal bleeding associated with aorto-digestive fistulas.Patients with aortic aneurysms or those who have undergone prosthetics should have increased alertness regarding the formation of aorto-digestive fistulas. With a presence of gastrointestinal bleeding and exclusion of other sources based on multispiral computed tomography data with intravenous bolus contrast enhancement, this will allow for quick verification of the diagnosis and also enable timely medical measures to be taken. In an emergency situation, to achieve rapid hemostasis in unstable patients, endovascular aortic replacement is most justified. Open reconstruction of the aorta in situ with simultaneous elimination of the hollow organ defect and sanitation of fistula-associated foci of infection should be considered as a radical intervention for aorto-digestive fistulas.Received 19 May 2021. Revised 7 July 2021. Accepted 9 July 2021.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.
23 December 2021 in Experimental and Clinical Gastroenterology
Non-alcoholic fatty liver disease (NAFLD) is a pressing public health problem affecting up to a third of the world's adult population. The main reasons for its high mortality rate are cardiovascular diseases. They are caused by subclinical atherosclerosis characteristic of NAFLD, venous thromboembolic complications, functional and structural myocardial disorders, calcification of heart valves, heart rhythm and conduction disturbances. At the same time, NAFLD can serve as an independent factor of the cardiometabolic risk of their development, which is associated with atherogenic dyslipidemia, as well as the release of numerous pro-inflammatory mediators both from the pathologically altered liver and as a result of systemic endotoxemia, which is the result of disturbance of the intestinal microbiota, accompanied by a decrease in intestinal microbial gene richness., a change in its composition and function, followed by bacterial translocation. Considering that most patients with NAFLD die from cardiovascular complications, it becomes obvious that exclusively “liver-oriented” principles of their treatment cannot be sufficient, but require a multidisciplinary team approach involving cardiologists, cardiac surgeons and doctors of other related specialties.
1 January 2019 in Russian Journal of Operative Surgery and Clinical Anatomy
1 January 2022 in Clinical and Experimental Surgery. Petrovsky journal
FFFederal Center For Cardiovascular Surgery (Chelyabinsk) Of The Ministry Of Healthcare Of The Russian Federation
Federal Center For Cardiovascular Surgery (Chelyabinsk) Of The Ministry Of Healthcare Of The Russian Federation
Абдоминальные осложнения после операций на сердце в условиях искусственного кровообращения: анализ данных за 2011-2021 гг.
1 August 2020 in Problems of Social Hygiene, Public Health and History of Medicine
The aim of this study was to analyze quality-of-life parameters in patients with coronary heart disease in Chelyabinsk region. The number of patients with coronary heart disease who took part in this research was 830 people. The data were collected with using of application form that was supplemented by the Russian-language questionnaire SF-36. We determined the medical and social characteristics, the assessment of the conditions and lifestyle of patients with coronary heart disease, and the subjective assessment of the quality of life by themselves. We have been revealed statistically significant differences in assessing the quality of life by patients of different territorial groups. The data should be differentially use in developing of regional and territorial programs in order to reduce mortality from coronary heart disease.